Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups
| EMCCX Fund | USD 57.10 0.01 0.02% |
Slightly above 56% of Empiric 2500's investor base is looking to short. The analysis of overall sentiment of trading Empiric 2500 Fund mutual fund suggests that many investors are alarmed at this time. Empiric 2500's investing sentiment can be driven by a variety of factors including economic data, Empiric 2500's earnings reports, geopolitical events, and overall market trends.
Empiric |
DUBLIN, August 23, 2023 Horizon Therapeutics plc today announced that it ranked first in overall corporate reputation among rare disease patient groups around the world who were familiar with the company. Rare disease patient groups who worked with Horizon also ranked the company first in 10 of the 14 indicators including patient centricity, patient information, integrity, access to medicines, relationships and services bey
Read at finance.yahoo.com
 |
Empiric 2500 Fundamental Analysis
We analyze Empiric 2500's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Empiric 2500 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Empiric 2500 based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Empiric 2500 is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Empiric 2500 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Empiric 2500 mutual fund to make a market-neutral strategy. Peer analysis of Empiric 2500 could also be used in its relative valuation, which is a method of valuing Empiric 2500 by comparing valuation metrics with similar companies.
Peers
Empiric 2500 Related Equities
| TIMTX | Transamerica Intermediate | 0.19 | ||||
| OWMBX | Old Westbury | 0.18 | ||||
| ABIMX | Ab Impact | 0.10 | ||||
| PRFHX | T Rowe | 0.09 | ||||
| CFNLX | National Tax | 0.05 |
Other Information on Investing in Empiric Mutual Fund
Empiric 2500 financial ratios help investors to determine whether Empiric Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Empiric with respect to the benefits of owning Empiric 2500 security.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |